Cargando…
Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)
Autores principales: | Belgodère, Laëtitia, Pougheon Bertrand, Dominique, Jaulent, Marie Christine, Rabeharisoa, Vololona, Janssens, Walter, Rollason, Victoria, Barbot, Janine, Vernant, Jean Paul, Oualikene Gonin, Wahiba, Maison, Patrick, Ankri, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201242/ https://www.ncbi.nlm.nih.gov/pubmed/37208125 http://dx.doi.org/10.1136/bmjgh-2023-011966 |
Ejemplares similares
-
Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products
por: Oualikene-Gonin, Wahiba, et al.
Publicado: (2023) -
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience
por: Belgodère, Laëtitia, et al.
Publicado: (2023) -
Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
por: Vignot, Stéphane, et al.
Publicado: (2021) -
L’ANSM et les faux prophètes de la Covid
por: Manus, Jean-Marie
Publicado: (2020) -
In Vitro Efficacy of Myxococcus fulvus ANSM068 to Biotransform Aflatoxin B(1)
por: Guan, Shu, et al.
Publicado: (2010)